r.rotation.to⌕ Search stocks, people, sectors
Request a free account

Follow the people · Insider

GN

George K. Ng

Insider · Chief Executive Officer · PCSA

George K. Ng files insider transactions with the SEC as a chief executive officer of Processa Pharmaceuticals (PCSA). We hold 10 disclosed purchases and sales filed since 5 August 2015, 2 of them in the last 90 days.

  • Files forPCSA
  • Disclosed buys and sells10 in all, 2 in the last 90 days
  • Last disclosure11 August 2026

Positions held

4 posts we hold — a term names its own dates; a run of filings only says when they filed
  • Filed 8 August 2023 — 8 August 2026Chief Executive Officer · Processa Pharmaceuticals (PCSA)24 Form 4 lines · source: SEC Form 4
  • Filed 2 January 2025 — 12 February 2026Director · TuHURA Biosciences, Inc./NV (HURA)3 Form 4 lines · source: SEC Form 4
  • Filed 18 October 2024 — 18 October 2024Director · Kintara Therapeutics (KTRA)3 Form 4 lines · source: SEC Form 4
  • Filed 3 August 2015 — 28 February 2018Officer · Sorrento Therapeutics (SRNE)12 Form 4 lines · source: SEC Form 4

Everything they disclosed

42 entries, newest first — one per disclosure report, one per Form 4 line

Positions come from the unitedstates/congress-legislators roster, the Office of Government Ethics and the SEC’s Form 4 index. Every disclosed line names its own source and links the document the government published; we print what the filing says and never a price we did not read from it. Headlines and links come from the GDELT Global Knowledge Graph — the story stays with the publisher. The portrait, where we have one, is the public-domain Congressional Bioguide photograph.